Journey Medical Corporation (DERM)

USD 7.36

(-1.6%)

Total Liabilities Summary of Journey Medical Corporation

  • Journey Medical Corporation's latest annual total liabilities in 2023 was 56.49 Million USD , down -35.93% from previous year.
  • Journey Medical Corporation's latest quarterly total liabilities in 2024 Q1 was 53.62 Million USD , down -5.1% from previous quarter.
  • Journey Medical Corporation reported annual total liabilities of 88.17 Million USD in 2022, up 59.62% from previous year.
  • Journey Medical Corporation reported annual total liabilities of 55.24 Million USD in 2021, up 32.75% from previous year.
  • Journey Medical Corporation reported quarterly total liabilities of 53.89 Million USD for 2024 Q2, up 0.51% from previous quarter.
  • Journey Medical Corporation reported quarterly total liabilities of 88.36 Million USD for 2023 Q1, up 0.21% from previous quarter.

Annual Total Liabilities Chart of Journey Medical Corporation (2023 - 2014)

Created with Highcharts 11.1.0YearsTotal Liabilities20142015201620172018201920202021202220230 USD100000000 USD200000000 USD300000000 USD400000000 USD500000000 USD

Historical Annual Total Liabilities of Journey Medical Corporation (2023 - 2014)

Year Total Liabilities Total Liabilities Growth
2023 56.49 Million USD -35.93%
2022 88.17 Million USD 59.62%
2021 55.24 Million USD 32.75%
2020 41.61 Million USD 33.78%
2019 31.1 Million USD -91.2%
2018 353.36 Million USD -14.05%
2017 411.14 Million USD 530.29%
2016 65.23 Million USD 78.93%
2015 36.45 Million USD 47.95%
2014 24.64 Million USD 0.0%

Peer Total Liabilities Comparison of Journey Medical Corporation

Name Total Liabilities Total Liabilities Difference
Intra-Cellular Therapies, Inc. 136.87 Million USD 58.721%
PainReform Ltd. 2.69 Million USD -1999.554%
Alvotech 1.88 Billion USD 96.999%
Collegium Pharmaceutical, Inc. 947.87 Million USD 94.039%
ANI Pharmaceuticals, Inc. 471.67 Million USD 88.022%
Aquestive Therapeutics, Inc. 163.9 Million USD 65.529%
Dynavax Technologies Corporation 375.02 Million USD 84.935%
Esperion Therapeutics, Inc. 660.79 Million USD 91.45%
Bright Green Corporation 6.43 Million USD -777.572%
Pacira BioSciences, Inc. 704.25 Million USD 91.977%
Embecta Corp. 2.03 Billion USD 97.225%
Sunshine Biopharma, Inc. 6.13 Million USD -820.239%
Sunshine Biopharma, Inc. 6.13 Million USD -820.239%
SCYNEXIS, Inc. 55.45 Million USD -1.892%
Petros Pharmaceuticals, Inc. 21.31 Million USD -165.057%
Silver Spike Investment Corp. 3 Million USD -1777.149%
China SXT Pharmaceuticals, Inc. 9.19 Million USD -514.346%
Alpha Teknova, Inc. 38.55 Million USD -46.557%
Safety Shot Inc 3.89 Million USD -1351.654%
Procaps Group, S.A. 462.06 Million USD 87.772%
Cosmos Health Inc. 30.25 Million USD -86.758%
Theratechnologies Inc. 98.63 Million USD 42.721%
Harrow Health, Inc. 241.75 Million USD 76.629%
Sonoma Pharmaceuticals, Inc. 8.75 Million USD -545.26%
Biofrontera Inc. 23.13 Million USD -144.172%
DURECT Corporation 30.4 Million USD -85.815%
Supernus Pharmaceuticals, Inc. 487.46 Million USD 88.41%
Cronos Group Inc. 43.73 Million USD -29.182%
OptiNose, Inc. 194.33 Million USD 70.927%
Ironwood Pharmaceuticals, Inc. 817.36 Million USD 93.088%
Kala Pharmaceuticals, Inc. 48.44 Million USD -16.625%
RedHill Biopharma Ltd. 20.97 Million USD -169.323%
Organogenesis Holdings Inc. 181.36 Million USD 68.847%
Guardion Health Sciences, Inc. 3.77 Million USD -1397.799%
Cumberland Pharmaceuticals Inc. 52.51 Million USD -7.584%
Radius Health, Inc. 804.29 Million USD 92.975%
Universe Pharmaceuticals INC 13.75 Million USD -310.772%
ProPhase Labs, Inc. 42.54 Million USD -32.801%
Phibro Animal Health Corporation 725.54 Million USD 92.213%
Procaps Group S.A. 462.06 Million USD 87.772%
TherapeuticsMD, Inc. 14.02 Million USD -302.931%
Viatris Inc. 27.21 Billion USD 99.792%
Rockwell Medical, Inc. 30.88 Million USD -82.951%
Aytu BioPharma, Inc. 90.37 Million USD 37.487%
SIGA Technologies, Inc. 57.97 Million USD 2.55%
Tilray Brands, Inc. 892.11 Million USD 93.667%
Lifecore Biomedical, Inc. 219.8 Million USD 74.295%
Shineco, Inc. 47.6 Million USD -18.691%
PetIQ, Inc. 645.22 Million USD 91.244%
Regencell Bioscience Holdings Limited 219.51 Thousand USD -25638.456%
Incannex Healthcare Limited 5.83 Million USD -869.108%
Neurocrine Biosciences, Inc. 1.01 Billion USD 94.458%
Alimera Sciences, Inc. 107.35 Million USD 47.371%
Assertio Holdings, Inc. 148.41 Million USD 61.932%
Shuttle Pharmaceuticals Holdings, Inc. 1.89 Million USD -2879.96%
Clever Leaves Holdings Inc. 7.02 Million USD -704.142%
Cyclo Therapeutics, Inc. 8.49 Million USD -565.435%
Avadel Pharmaceuticals plc 173.38 Million USD 67.415%
Hempacco Co., Inc. 18.82 Million USD -200.169%
Talphera, Inc. 6.29 Million USD -798.235%
Alvotech 1.88 Billion USD 96.999%
Eagle Pharmaceuticals, Inc. 172.6 Million USD 67.266%
Lantheus Holdings, Inc. 835.25 Million USD 93.236%
Currenc Group, Inc. 177.67 Million USD 68.201%
Kamada Ltd. 109.96 Million USD 48.622%
Indivior PLC 1.95 Billion USD 97.104%
Evoke Pharma, Inc. 9.64 Million USD -485.598%
Flora Growth Corp. 17.22 Million USD -228.063%
Cyclo Therapeutics, Inc. 8.49 Million USD -565.435%
Evolus, Inc. 209.68 Million USD 73.056%
HUTCHMED (China) Limited 536.38 Million USD 89.467%
Amphastar Pharmaceuticals, Inc. 873.49 Million USD 93.532%
Akanda Corp. 12.66 Million USD -345.967%